Monitoring COVID‐19 and Influenza: The Added Value of a Severe Acute Respiratory Infection Surveillance System in PortugalAna Rita Torres, Ausenda Machado, Verónica Gomez et al.|Canadian Journal of Infectious Diseases and Medical Microbiology|2023Cited by 18
SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)Irina Kislaya, João Almeida Santos, Sofia Soeiro et al.|Scandinavian Journal of Infectious Diseases|2022Cited by 16
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024Lore Merdrignac, Charlotte Lanièce Delaunay, Nuno Verdasca et al.|Influenza and Other Respiratory Viruses|2024Cited by 14
Resurgence of Respiratory Syncytial Virus in Children: An Out-of-Season Epidemic in PortugalAna Rita Torres, On behalf of Laboratórios para o Diagnóstico da Gripe, Raquel Guiomar Guiomar et al.|Acta Médica Portuguesa|2023Cited by 11
COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care NetworkCharlotte Lanièce Delaunay, Nuno Verdasca, Susana Monge et al.|Influenza and Other Respiratory Viruses|2025Cited by 10